According to the study, circSTIL inhibits ferroptosis and increases CRC cell proliferation through the miR-431/SLC7A11 signaling pathway, indicating possible targets for CRC therapy (Li et al., 2023[125]). The gene discussed is SLC7A11; the disease is colorectal carcinoma.